Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to compare glofitamab plus chemotherapy with rituximab plus chemotherapy in people with diffuse large B-cell lymphoma (after previous treatment has not worked).

    A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    • Cancer
    • Non Hodgkin Lymphoma (NHL)
    • Diffuse Large B-Cell Lymphoma (DLBCL)